South Korea signs for extra 40 million Covid-19 vaccine doses with Pfizer
The country said that it had also secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
South Korea said on Saturday it signed a contract with Pfizer Inc to purchase an additional 40 million doses of its COVID-19 vaccine amid fears of spiking infections at home.

That brings the current amount of Pfizer vaccines to 66 million doses, it said in a statement.
It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.

E-Paper

